IMAGINARY Math Exhibition using Low-cost 3D Printers

Autor: Rainone, M., Fonda, C., Canessa, E.

We have made an attempt to reproduce 17 objects of the IMAGINARY Open Mathematics Exhibition (www.imaginary.org) using low-cost, desktop 3D printers. The IMAGINARY open math is an international project by the Mathematisches Forschungsinstitut Oberwol

Externí odkaz: http://arxiv.org/abs/1409.5595

Thrombopoietin Receptor Agonists for Thrombocytopenia Secondary to HER2-Targeted Antibody Drug Conjugates.

Autor: Rainone M; Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope Comprehensive Cancer Center, Duarte, CA, USA., Kasparian S; Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope Comprehensive Cancer Center, Duarte, CA, USA., Nguyen T; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope Comprehensive Cancer Center, Duarte, CA, USA., Talwar N; Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA, USA., Yuan Y; Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.; Department of Medical Oncology, Cedars-Sinai Medical Center, Los Angeles, CA, USA., Mei M; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope Comprehensive Cancer Center, Duarte, CA, USA., Mortimer JE; Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA, USA., Waisman JR; Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA, USA., Patel N; Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.; Department of Medical Oncology, Cedars-Sinai Medical Center, Los Angeles, CA, USA., Pullarkat V; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.

Publikováno v: The oncologist [Oncologist] 2023 Sep 07; Vol. 28 (9), pp. e843-e846.

Polypharmacy Management in a Gender Perspective: At the Heart of the Problem: Analysis of Major Cardiac Diseases, SARS-CoV-2 Affection and Gender Distribution in a Cohort of Patients in Internal Medicine Ward.

Autor: Pietrantonio F; Ospedale dei Castelli, Local Health Authority Roma 6, 00041 Albano Laziale, Italy.; National Centre for Health Technology Assessment, National Health Institute, 00153 Rome, Italy., Ciamei A; Ospedale dei Castelli, Local Health Authority Roma 6, 00041 Albano Laziale, Italy., Vinci A; Department of Biomedicine and Prevention, University of Rome 'Tor Vergata', 00133 Rome, Italy., Ciarambino T; Department of Internal Medicine, Luigi Vanvitelli University, 81100 Caserta, Italy., Alessi E; Ospedale dei Castelli, Local Health Authority Roma 6, 00041 Albano Laziale, Italy., Pascucci M; Ospedale dei Castelli, Local Health Authority Roma 6, 00041 Albano Laziale, Italy., Delli Castelli M; Ospedale dei Castelli, Local Health Authority Roma 6, 00041 Albano Laziale, Italy., Zito S; Ospedale dei Castelli, Local Health Authority Roma 6, 00041 Albano Laziale, Italy., Sanguedolce S; Ospedale dei Castelli, Local Health Authority Roma 6, 00041 Albano Laziale, Italy., Rainone M; Ospedale dei Castelli, Local Health Authority Roma 6, 00041 Albano Laziale, Italy., Di Lorenzo J; Ospedale dei Castelli, Local Health Authority Roma 6, 00041 Albano Laziale, Italy., Vinci F; Ospedale dei Castelli, Local Health Authority Roma 6, 00041 Albano Laziale, Italy., Laurelli G; Ospedale dei Castelli, Local Health Authority Roma 6, 00041 Albano Laziale, Italy., Di Iorio C; Ospedale dei Castelli, Local Health Authority Roma 6, 00041 Albano Laziale, Italy., Corsi R; Health Management, Local Health Authority Roma 6, 00041 Albano Laziale, Italy., Ricci S; Department of Hystological, Anatomical Sciences and Legal Medicine, Sapienza-University of Rome, 00196 Rome, Italy., Di Berardino A; Ospedale dei Castelli, Local Health Authority Roma 6, 00041 Albano Laziale, Italy., Ruggeri M; National Centre for Health Technology Assessment, National Health Institute, 00153 Rome, Italy.; HTA Center, St. Camillus University of Medicine and Health Sciences, 00131 Rome, Italy., Rosiello F; Ospedale dei Castelli, Local Health Authority Roma 6, 00041 Albano Laziale, Italy.; Department of Hystological, Anatomical Sciences and Legal Medicine, Sapienza-University of Rome, 00196 Rome, Italy.

Publikováno v: International journal of environmental research and public health [Int J Environ Res Public Health] 2023 May 03; Vol. 20 (9). Date of Electronic Publication: 2023 May 03.

Methylation Analyses Reveal Promoter Hypermethylation as a Rare Cause of "Second Hit" in Germline BRCA1-Associated Pancreatic Ductal Adenocarcinoma.

Autor: Zheng-Lin B; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Rainone M; Department of Medical Oncology, City of Hope National Medical Center, Duarte, CA, USA., Varghese AM; Gastrointestinal Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, 300 East 66th Street, Office 1021, New York, NY, 10065, USA., Yu KH; Gastrointestinal Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, 300 East 66th Street, Office 1021, New York, NY, 10065, USA., Park W; Gastrointestinal Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, 300 East 66th Street, Office 1021, New York, NY, 10065, USA.; Weill Cornell Department of Medicine, Weill Cornell Medicine, New York, NY, USA.; David M. Rubenstein Center for Pancreatic Research, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Berger M; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Mehine M; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Chou J; Department of Epidemiology and Biostatistics, Weill Cornell Medical College, New York, NY, USA., Capanu M; Department of Epidemiology and Biostatistics, Weill Cornell Medical College, New York, NY, USA., Mandelker D; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Stadler ZK; Gastrointestinal Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, 300 East 66th Street, Office 1021, New York, NY, 10065, USA.; Weill Cornell Department of Medicine, Weill Cornell Medicine, New York, NY, USA.; David M. Rubenstein Center for Pancreatic Research, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Birsoy O; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Jairam S; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Yang C; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Li Y; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Wong D; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Benhamida JK; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Ladanyi M; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Zhang L; Department of Pathology and Laboratory Medicine, University of California, Los Angeles (UCLA), 10833 Le Conte Ave, Los Angeles, CA, 90095, USA. LiyingZhang@mednet.ucla.edu., O'Reilly EM; Gastrointestinal Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, 300 East 66th Street, Office 1021, New York, NY, 10065, USA. oreillye@mskcc.org.; Weill Cornell Department of Medicine, Weill Cornell Medicine, New York, NY, USA. oreillye@mskcc.org.; David M. Rubenstein Center for Pancreatic Research, Memorial Sloan Kettering Cancer Center, New York, NY, USA. oreillye@mskcc.org.

Publikováno v: Molecular diagnosis & therapy [Mol Diagn Ther] 2022 Nov; Vol. 26 (6), pp. 645-653. Date of Electronic Publication: 2022 Sep 30.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.